Poster Presentations: Clinical: Diagnosis and Outcome 2023

P120 Development and validation of a dedicated score to assess transmural response and transmural healing in patients with Crohn’s disease : final results of the DEVISE-CD project

P121 Clinicomic profiles new feature patterns based on a simplified location classification for Crohn’s disease

P122 External validation of the Picasso Histological Remission Index (PHRI) to assess endoscopic and histological remission and predict long-term outcome in Ulcerative Colitis: A multicentre prospective study.

P123 Development of an end-to-end Mayo endoscopic score machine learning algorithm for use in clinical trials of ulcerative colitis

P124 Risk of surgery in inflammatory bowel disease: A systematic review and meta-analysis of sex-based differences

P125 LCI/BLI chromoendoscopy plus CAD-EYE artificial intelligence for the detection and characterization of endoscopic visible lesions in ulcerative colitis

P126 Ask twice: The importance of repeated faecal calprotectin testing prior diagnostic colonoscopy in an adult inception cohort.

P127 Inflammatory Bowel Disease-associated colorectal cancers: retrospective cohort study from a tertiary centre surveillance programme over 10 years

P128 The role of small bowel capsule endoscopy as a diagnostic tool in isolated complex perianal disease

P129 Intestinal ultrasound at week 12 predicts long-term endoscopic response to biologics in ulcerative colitis

P130 Intestinal ultrasound combined to fecal calprotectin is effective to predict endoscopic mucosal healing in ulcerative colitis: a cross-sectional study

P131 Is stress associated with subclinical inflammation in Ulcerative Colitis? A population-based cross-sectional cohort study in southeastern Sweden

P132 Prognosis and molecular characteristics of IBD-associated colorectal cancer: experience from a French tertiary-care center

P133 Risk Factors for the Occurrence and Severity of Vertebral Fractures in Inflammatory Bowel Disease Patients: A Nationwide Population-Based Cohort Study

P134 Pediatric granulomatous appendicitis, how can it be precursor of Crohn Disease?

P135 Atopic dermatitis is associated with the clinical course of inflammatory bowel disease

P136 Multidimensional assessment of visceral hypervigilance in patients with IBD

P137 The prevalence and severity of sexual dysfunction in male IBD patients: an observational single-center study

P138 The use of video capsule endoscopy (vce) in patinets with a new diagnosis of Crohn's disease: the experience of one center

P139 Inflammatory bowel disease and impairment of working life

P140 Costs of home-monitoring by telemedicine versus standard care management of Inflammatory Bowel Disease – a Danish register-based five-year follow-up study

P141 Risk Factors of Atherosclerotic Cardiovascular Disease (Ischemic Heart Disease and Cerebrovascular Accident) in Patients With Inflammatory Bowel Disease: a hospital-based cohort

P142 Evaluation of quantitative phase imaging for automated assessment of histopathological remission in patients with Ulcerative Colitis

P143 Outcomes of ulcerative colitis-associated dysplasia patients treated with endoscopic submucosal dissection: An extended analysis of a single center cohort

P144 Impact of major medication discontinuation during the first wave of COVID-19 pandemic on the risk of early relapse in patients with inflammatory bowel disease: a French observational retrospective study

P145 Phenotypic progression of Crohn’s disease : assessment of risk factors in a Tunisian population

P146 Stigmatization and resilience in inflammatory bowel disease patients at one-year follow-up

P147 Trends in choice of first line biologic therapy for patients with Inflammatory Bowel Disease. An observational cohort study.

P148 Work Ability Index (WAI) as a suitable instrument to assess work ability among IBD patients

P149 Novel capillary blood point-of-care test for adalimumab and infliximab trough levels: Effects of abnormal blood conditions on the test result

P150 Identification of features associated with poor outcomes in pediatric patients with ulcerative proctitis: A Multicentre Study From the Paediatric IBD Porto Group of ESPGHAN

P151 Assessing comprehensive remission for Ulcerative Colitis in clinical practice: International consensus recommendations

P152 The prevalence of Thiopurine-methyltransferase and NUTD15 in patient with ulcerative colitis: a hospital-based study in central Taiwan

P153 Association between ustekinumab trough concentrations and clinical, biochemical, and endoscopic outcomes in patients with Inflammatory Bowel Disease

P154 A novel serum protein signature as biomarker for Inflammatory Bowel Disease: A diagnostic performance and prediction modelling study using data from two independent inception cohorts

P155 Natural history of anal stricture in pediatric-onset Crohn’s disease: a two-decades population-based study

P156 Submucosa hypertrophy of active UC patients suggests transmural involvement in UC-associated inflammation

P157 Serial daily recording of patient-reported outcomes (PRO2) might predict treatment change in the patients with Ulcerative Colitis.

P158 Intestinal Ultrasound at IBD diagnosis predicts surgery – a Copenhagen IBD cohort study

P159 Development of a core set of quality of care measurements for patients with inflammatory bowel disease in Belgium

P160 Influence of sarcopenia on perioperative management and postoperative outcome in patients with Crohn’s Disease undergoing intestinal surgery: a retrospective study

P161 Simplified Endoscopic Mucosal Assessment for Crohn’s Disease (SEMA-CD): External Application and Prognostic Value Definition.

P162 Earlier (luminal) surgery is associated to reduced postoperative morbidity in ileocaecal Crohn’s disease: results from SURGICROHN – LATAM study.

P163 Is Peri-appendiceal Inflammation of Clinical Significance in Patients with Ulcerative Colitis?

P164 Dysplasia detection rates in a surveillance program real-world data from a tertiary referral center for inflammatory bowel diseases

P165 Vitamin D deficiency is associated with poor sleep quality in patients with Crohn’s disease

P166 Calprotectin in patients with perianal fistula: the CANALS study

P167 Ileocecal valve that cannot be intubated during colonoscopy in patients with Crohn’s disease: Is this a sign of poor prognosis?

P168 Development of predictive model for early detection of Inflammatory Bowel Disease in Korea

P169 Copy number variation of alpha defensin 1-3 is a predictive marker of therapeutic response in ulcerative colitis

P170 Can histological activity of ulcerative colitis be predicted by assessment of the rectosigmoid colon?

P171 Subfertility in young patients with Crohn´s disease. A case-control study.

P172 Metabolic disorders with non-alcoholic fatty liver disease in people with inflammatory bowel disease

P173 Patency capsule: A novel independent predictor for long-term outcomes among patients with quiescent Crohn’s disease

P174 Uncontrolled depression and female gender increase the risk of severe fatigue in patients with inflammatory bowel disease under infliximab therapy.

P175 Burden of Inflammatory Bowel Disease in Mexico: RISE-MX, a Multi-center, Retrospective, 3-Year Data Study

P176 Clinical features of acute severe ulcerative colitis according to steroid dependency: A KASID multicenter study

P177 C-reactive protein/albumin ratio: a novel biomarker for monitoring of the disease activity in Ulcerative Colitis patients

P178 Evaluation of the Ulcerative Colitis Intestinal Ultrasound (UC-IUS) Index in Pediatric patients with newly diagnosed ulcerative colitis

P179 Comparative benefit-risk profile of induction and maintenance therapy with upadacitinib versus placebo in patients with moderately to severely active ulcerative colitis

P180 Ileorectal anastomosis preserves female fertility after colectomy in Ulcerative Colitis

P181 infliximab exposure during induction associate with time to remission and disease control of inflammatory bowel disease

P182 Modified Multiplier SES-CD (MM-SES-CD) and laboratorial Crohn’s disease activity parameters: is there any association?

P183 Development of a new simple ultrasound activity score for intestinal Behçet's Disease

P184 Identification of the PAI-1, as a potential non-invasive, fecal biomarker in the Inflammatory Bowel Diseases

P185 Global perception of normal life by healthcare professionals and IBD patients: mind the gap

P186 Impact of tofacitinib maintenance therapy on key Ulcerative Colitis patient-reported outcomes of fatigue, urgency, abdominal pain and sexual dysfunction using IBDQ and SF-36 individual items as proxies

P187 Intestinal ultrasound is accurate for detecting intra-abdominal complications in Crohn’s disease: a meta-analysis

P188 Middle small-bowel segment Lewis score may predict long-term outcomes among patients with quiescent Crohn’s disease

P189 Prospective Validation Study Regarding Disease Complications of the Toronto IBD Global Endoscopic Reporting (TIGER) Score in Ulcerative Colitis and Crohn’s Disease Patients

P190 Delayed IBD diagnosis leads to worse outcomes over years, with multiple implications on service delivery

P191 Robotic Surgery shows significant promise in delivering superior outcomes for patients with Inflammatory Bowel Disease

P192 Comparison of Endoscopic Scoring System and Simplified Magnetic Resonance Index of Activity in Patients with Small Bowel Crohn’s Disease: Basis for Therapeutic Plan?

P193 Predicting the middle-term efficacy of molecular-targeted medications for Ulcerative Colitis based on the intestinal ultrasound findings

P194 Characterization of Protein Disulfide Isomerases in adult and pediatric Crohn’s Disease and association with inflammation and fibrosis

P195 Is fecal calprotectin truly valuable in the management of isolated small bowel Crohn’s disease?

P196 Major variance in scoring of endoscopic recurrence after ileocolic resection for Crohns Disease – a systematic review and meta-analysis

P197 A biomarker of early mucosal destruction: Neutrophil-mediated type IV collagen degradation is elevated in patients with Crohn’s Disease and Ulcerative Colitis

P198 Sonographic features of colonic pseudopolyposis in inflammatory bowel diseases

P199 Clonal patterns between pouch neoplasia and prior colorectal neoplasia in Inflammatory Bowel Disease patients: an exploratory cohort study

P200 Hepatic Steatosis but not Fibrosis is independently associated with poor outcomes in patients with Inflammatory Bowel Disease

P201 Assessment of factors associated with cumulative bowel damage in surgically naïve patients using Lemann index and global MaRIA index in Crohn’s disease

P202 Accuracy of blood-PCR for diagnosing CMV Colitis in patients with Inflammatory Bowel Disease

P203 Oral omeprazole and diclofenac intake is associated with increased faecal calprotectin levels: a randomised open-label clinical trial

P204 Preoperative optimization of patients with inflammatory bowel disease: a multicentre study of EIGA Group

P205 Impact of histologic disease activity on long-term outcomes in patients with ileal pouch-anal anastomosis for ulcerative colitis

P206 Artificial Intelligence reproduces central reading for automated scoring of colonoscopies from multiple clinical trials in Ulcerative Colitis.

P207 Colonic location at diagnosis of pediatric-onset Crohn’s disease is associated with a pejorative disease course: a two decades population-based study

P208 Validation of the IBD-Disk in a Portuguese cohort of patients with inflammatory bowel disease

P209 Delayed IBD diagnosis increases risk of requiring biologics in first 4-years - an Inception cohort study

P210 Long-term outcome of very early onset inflammatory bowel disease associated with primary sclerosing cholangitis: a multicenter study from the Pediatric IBD Porto Group of ESPGHAN

P211 Factors associated with estimated cardiorespiratory fitness in patients with Inflammatory Bowel Disease: an exploratory analysis of real-world data

P212 The Impact of Crohn’s Disease in Patients with Colorectal Cancer: A Danish Nationwide Cohort Study, 2009-2019

P213 High prevalence and risk factors for nonalcoholic fatty liver disease in patients with Crohn's disease

P214 Cine MRI assessment of colonic motility in patients with ulcerative colitis associated constipation.

P215 Deep immune phenotyping of unconventional T cells reveals a depletion in Mucosa Associated T Cells (MAIT) in IBD patients with extraintestinal manifestations

P216 Oral Budesonide and low serum albumin levels at surgery are associated with a higher risk of postoperative intra-abdominal septic complications after primary ileocecal resection for Crohn’s disease: a retrospective analysis of 853 consecutive patient

P217 Volatile organic metabolites to predict clinical response to biological therapy in inflammatory bowel disease

P218 It is time to grow up: readiness is associated with better outcomes in a prospective study of pediatric transition patients with Inflammatory Bowel Disease

P219 Migraine Is Associated with the Development of Inflammatory Bowel Disease: A Nationwide, Population-Based Study

P220 Patient’s disease perception and health-related quality of life with IBD: Results from a Spanish cohort with 15 years of follow up

P221 Validity of the Self-administered Comorbidity Questionnaire in patients with Inflammatory Bowel Disease

P222 Chronic pain is common in Paediatric Inflammatory Bowel Disease and impacts quality of life

P223 The usefulness of tissue calprotectin in pediatric Crohn’s disease – a pilot study.

P224 Diagnostic delay in inflammatory bowel disease is not associated with difficult access to healthcare facilities: a clinical study on incidental cases

P225 The accuracy of different intestinal ultrasound parameters in detecting endoscopic activity in patients with inflammatory bowel disease

P226 Dietary patterns differ in the newly diagnosed IBD cohort with ethnicity as a key confounding variable, a case control study

P227 Patient experiences in ulcerative colitis: conceptual model and review of patient-reported outcome measures

P228 Machine learning models utilizing simple laboratory tests may assess endoscopic activity in ulcerative colitis

P229 Comparison of the characteristics of segmental mucosal microbiome according to the extent of inflammation in ulcerative colitis.

P230 Adalimumab in Crohn’s disease is protective against periodontitis based on a validated oral health questionnaire

P231 Impact of age of Inflammatory Bowel Disease diagnosis on disease phenotype and severity in elderly patients

P232 Serum neutrophil gelatinase associated lipocalin (NGAL) as a marker of activity of Inflammatory Bowel Disease

P233 Malnutrition diagnosis based on the GLIM criteria and patients’ dietary beliefs and practices impact negatively the quality of life of IBD patients

P234 Differentiation of histopathological features between sporadic and colitis-associated colorectal cancer in a nationwide large cohort.

P235 Patients with inflammatory ileal pouch anal anastomosis (IPAA) disorders are characterized by a distinct breath volatile organic compounds (VOC) metabolome profile

P236 Endoscopic Recurrence or Anastomotic Wound Healing Phenomenon after Ileocolic Resection for Crohn’s Disease: The Challenges of Accurate Endoscopic Scoring

P237 Superior predictive value of intestinal ultrasound over endoscopic severity for colectomy risk in patients with ulcerative colitis

P238 The ‘Malnutrition Universal Screening Tool’ (MUST) is less effective than an IBD specific Malnutrition Inflammation Risk Tool (MIRT) in identifying malnutrition risk with hospital admissions and surgical complication

P239 Incidence of Long COVID and impact of medications on the risk of developing Long COVID in a nationwide cohort of Inflammatory Bowel Disease patients

P240 Low surgery rates first year after diagnosis in Crohn’s disease; results from a large population-based inception cohort - the IBSEN III study

P241 Gastrointestinal ultrasonography diagnostic performance and feasibility in IBD during pregnancy: a systematic review and narrative synthesis.

P242 Universal exclusion of patients with Permanent Ileostomy in Crohn’s disease clinical trials: A systematic review

P243 The association between serological markers ASCA and ANCA and response to induction treatment in therapy-naïve children with inflammatory bowel disease: an international prospective study

P244 Prognostic Value of post-biological induction fecal calprotectin concentration on the long-term outcomes of Crohn’s disease

P245 The Relationship Between the Endoscopic Healing Index and Magnetic Resonance Enterography In Crohn’s Disease Patients

P246 2D Shear Wave Elastography as novel tool for the assessment of disease severity in patients with IBD

P247 Oncostatin M and its receptor are markers of endoscopic and histological disease activity in Inflammatory Bowel Disease

P248 The diagnostic accuracy of Intestinal ultrasound for assessing disease activity in the proximal ileum and jejunum in children with Crohn’s disease: Preliminary results of a prospective study

P249 Colonic Explant Lactate Concentration and Disease Progression in Ulcerative Colitis

P250 The impact of Primary Sclerosing Cholangitis (PSC) on fecal calprotectin assessment in individuals with Inflammatory Bowel Disease (IBD)

P251 Level of Interleukin-17 in Inflammatory Bowel Disease and Its relation to disease activity.

P252 Solid organ transplant (with the exception of liver) in patients with inflammatory bowel disease: An ECCO CONFER Multicentre Case Series

P253 Histological Remission and Activity as Predictor of Relapse, Hospitalization, and Surgery in Ulcerative Colitis: Systematic Review and Meta-analysis

P254 Deep Learning Model for Distinguishing MES 0 and MES 1 in Patients with Ulcerative Colitis

P255 Diagnostic delay and economic burden in Inflammatory Bowel Disease: a single-centre experience in patients treated with biologics

P256 Urinary lithogenic profile and gut and urinary microbiota in patients with inflammatory bowel diseases

P257 Is colorectal screening in IBD fit for purpose?

P258 The association between dietary quality and disease severity in Korean young adult patients with Crohn’s disease: A pilot study

P259 Correlation between the Mayo endoscopic scoring system for Ulcerative Colitis with histological and clinical outcomes

P260 Care pathway modelling and economic analysis of a single NHS IBD Service following introduction of Small bowel ultrasound.

P261 Rate of Community Acquired Pneumonia, related hospitalization, and mortality among younger unvaccinated Inflammatory Bowel Disease patients

P262 Development and validation of a score predicting non-response to intravenous corticosteroids in patients with Acute Severe Ulcerative Colitis on day 3 of admission

P263 Raman spectroscopy analysis of saliva combined with an artificial neural network algorithm could discriminate between Ulcerative Colitis and Crohn’s disease

P264 Machine learning can accurately predict development of Inflammatory Bowel Disease

P265 Evaluation of the quality-of-care parameters in patients with inflammatory bowel disease in Brazilian hospitals

P266 Potential oral microbial markers for differential diagnosis of Crohn’s disease and ulcerative colitis using machine learning model

P267 Real-world artificial intelligence-aided colonoscopy does not improve adenoma detection rates in patients with Inflammatory Bowel Disease

P268 Development and validation of a novel composite index for the assessment of endoscopic and histologic disease activity in pouchitis: The Atlantic pouchitis index.

P269 Predicting IBD years before diagnosis using routine blood tests

P270 A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn’s disease

P271 Variability in histologic activity of paired same-segment biopsies in Crohn’s disease dictates multiple biopsies needed to accurately evaluate histological status

P272 Reduced delay in diagnosis of Crohn’s disease in patients presenting with perianal disease: results of a retrospective cohort study at a non-academic, IBD-expert centre in the Netherlands

P273 Severity of colitis and clinical outcomes for patients admitted with acute UC in 2 large UK centres

P274 Clinical manifestations, risk factors and prognostic factors of Cytomegalovirus Colitis in Inflammatory Bowel Disease patients

P275 Anastomotic technique drives endoscopic recurrence in Postoperative Crohn's Disease: a systematic review and meta-analysis

P276 Development and validation of a computed tomography-based radiomic nomogram to predict early-onset surgery risk in patients with Crohn’s disease

P277 Predicting disease relevant features in Crohn’s Disease and Ulcerative Colitis from Haematoxylin & Eosin stained whole slide images using self-supervised deep learning

P278 Endoscopic scoring system utilization for Inflammatory Bowel Disease activity assessment: a multicenter real-world evidence study from Argentina (DARE study)

P279 Ileo-caecal stenosis in Crohn's disease: correlation between imaging, biology and endoscopy : preliminary results of a prospective study

P280 Quality of life in military patients with Inflammatory Bowel Disease

P281 Conversion of the ileal pouch-anal anastomosis to a continent ileostomy – outcome and patient satisfaction

P282 Isolated colonic Crohn’s disease and extensive ulcerative colitis: is there a reel difference?

P283 Awareness and perceptions of colorectal cancer risk and screening in Inflammatory Bowel Disease

P284 Assessing Patient Experience in an Inflammatory Bowel Disease service. Can we measure an effect from socioeconomic deprivation – experience from the AWARE-IBD programme?

P285 Correlation between the endoscopic scoring system SES-CD for Crohn’s disease with histological and clinical outcomes

P286 Combined F18-FDG-PET-MRI-imaging: A promising tool for diagnostics of small bowel Crohn’s disease

P287 Clinical characteristics and outcomes of ileal pouch–anal anastomosis (IPAA) inflammation in a Latin American (LA) IBD reference Center (I.

P288 Application of a new classification of Fistulizing Perianal Crohn's Disease (FPCD) in clinical practice: evaluating the correlation between clinician and patient’s assessments and FPCD patient´s quality of life

P289 Hyperoxaluria in patients after ileocolic resection

P290 Development of an artificial intelligence model using stool pictures for predicting endoscopic mucosal inflammation in patients with Ulcerative Colitis; KASID multicenter study

P291 Long term outcomes of children with ulcerative colitis after acute severe colitis: a multicenter study from the GETAID pédiatrique group

P292 Complications in elderly-onset Inflammatory Bowel Diseases – A population-based study from the epidemiological database of the Israeli IBD Research Nucleus (Epi-IIRN)

P293 Correlation between clinical measures to capture disease burden and prediction of the initial course of Crohn’s disease - findings from a Copenhagen IBD Inception Cohort Study (IBD Prognosis Study)

P294 Assessment of Fatigue and Associated Factors in Patients with Inflammatory Bowel Disease: A Questionnaire-based Study

P295 Hocus Pocus: The Role Of Hand-Held Ultrasonography In Predicting Disease Extension And Endoscopic Activity In Ulcerative Colitis

P296 MAGNIFI-CD index is appropriate for treatment monitoring in perianal Crohn’s Disease

P297 The Toronto IBD Global Endoscopic Reporting (TIGER) Score and its Ability to Predict Outcomes Regarding Steroid and Biologic Use in Ulcerative Colitis and Crohn’s Disease Patients – A Construct Validation Study

P298 Risk factors for the progression of non-alcoholic fatty liver disease in people with inflammatory bowel disease

P299 Disability in newly diagnosed patients with Crohn´s Disease: initial results from the prospective CROCO (Crohn´s Disease Cohort) Study

P300 Overweight and obesity in Inflammatory Bowel disease: epidemiology, disease course and treatment outcomes

P301 Outcomes following colectomy for patients with Ulcerative Colitis, ten years of data from a tertiary referral centre

P302 Precision medicine for a case with monogenic inflammatory bowel disease

P303 Ultrasound is effective to identify mucosal healing in Crohn's disease patients : results of a cross-sectional study

P304 Leucine-rich alpha 2 glycoprotein reduces the necessity for endoscopic examination for activity evaluation

P305 Normal reference ranges and cut-off values for considering and performing endoscopy using the Sentinel CaliaGold® Calprotectin assay

P306 Serum tryptophan metabolites as a biomarker for disease severity in patients with IBD

P307 High frequency of Deep Infiltrating Endometriosis in patients with Inflammatory Bowel Disease: a nested case-control study

P308 A new endoscopic scoring system corresponding to histological healing using linked color imaging in ulcerative colitis: SOUL study

P309 Accuracy of PanMayo endoscopic score in predicting long-term disease outcomes in ulcerative colitis– a promising scoring system

P310 Smoking is not an independent risk factor for surgery in patients with Crohn’s Disease on biologic therapy

P311 Reliability of computed tomography enterography for evaluation of stricturing Crohn’s disease: Development of a Crohn’s disease stricture index

P312 Retrospective study using ultrasonography in predicting clinical relapse of Crohn's disease

P313 Understanding Inflammatory Bowel Disease patients’ experiences, expectations, and insights in identifying and managing anxiety and depression.

P314 Microscopic appendicitis in ulcerative colitis: Feasibility of ultrasonographic diagnosis

P315 The characteristics and severity of pediatric ulcerative proctitis

P316 Inflammatory Bowel Disease and malignancy: What are the predictors of malignancy in Inflammatory Bowel Disease?

P317 Patient satisfaction in a joint fistula clinic at a tertiary Inflammatory Bowel Disease centre in the United Kingdom

P318 Protein FingerPrint assays reflecting neutrophil activity, mucosal damage, and tissue fibrosis are surrogate biomarkers for mucosal healing in pediatric Crohn’s disease

P319 Characteristics of filgotinib-treated patients with Ulcerative Colitis who achieve sustained corticosteroid-free remission: Post hoc analysis of the phase 2b/3 SELECTION study

P320 Confocal Laser Endomicroscopy to predict the efficacy of vedolizumab as first-line biotherapy in ulcerative colitis

P321 Increased modified DUBLIN scores are associated with serious ulcerative colitis and treatment failure

P322 Mycobiome signature in pediatric patients with Inflammatory Bowel Disease

P323 The Rate of and Risk of Dysplasia in Long Standing Ulcerative Colitis Patients Among Middle-Eastern Population

P324 Long-term impact of the COVID-19 pandemic on Inflammatory Bowel Disease healthcare utilization: A two-year nationwide update

P325 Proton pump inhibitors are associated with a disabling course of Crohn’s disease

P326 PREFAB-study: PRediction tool for Early identification of patients at risk of Crohn's disease in perianal Fistulas and ABscesses: interim analysis of a prospective pilot study at a non-academic, IBD-expert centre in the Netherlands

P327 Characteristics of esophago-gastro-duodenal Crohn's disease in the biologic era: a nationwide study of the Young GETECCU Group

P328 Holistic well-being as Patient-reported outcomes (PROs) in translational IBD research: Prospective capture of CUCQ32 as study endpoints for mechanistic biomarker MUSIC/GIDAMPs study.

P329 Stool multiplex molecular PCR assay in comparison to conventional stool tests for detecting gastrointestinal infections as cause of flares in Inflammatory Bowel Disease

P330 Ultrasound remission after biologic induction predicts long-term endoscopic remission in Crohn’s disease

P331 Risk Factors and Prediction Model for Fecal Incontinence in Patients with Crohn’s Disease: A Multicenter Study

P332 External validation of intestinal ultrasound scores to detect endoscopic activity in children and adults with Crohn's disease: A prospective cohort study

P333 Early intestinal ultrasound remission is associated with endoscopic healing after one year of infliximab therapy in Crohn’s disease: a multicentre prospective study

P334 Respiratory Manifestations and Association Between Disease Activity in Patients with Inflammatory Bowel Disease in a Reference Center in Salvador, Bahia, Brazil.

P335 Impact of cancer therapy on the course of Inflammatory Bowel Disease (ONCOEII study of GETECCU)

P336 Endoscopic scores as predictors of treatment failure in Ulcerative Colitis

P337 Developing Preliminary MRI-based Classifier for Perianal Fistulizing Crohn’s Disease by Using Deep Convolutional Neural Networks

P338 Transmural healing is not associated with less disability than complete endoscopic mucosal healing: a prospective study in a patient with Crohn's disease

P339 Zonulin concentration in patients with ulcerative colitis with and without COVID-19 infection

P340 Issues on implementing treat-to-target approach in Asia Pacific, Middle East and Africa: Reality, gaps, and way forward -APMA IBD Coalition

P341 Fracture risk in middle-age and older patients with inflammatory bowel disease: A Korean nationwide population-based cohort study

P342 Treatment experience of perianal fistulising Crohn’s disease: a systematic literature review

P343 Eosinophilic inflammation as an indicator of the activity of the course of Inflammatory Bowel Diseases

P344 Diverting ileostomy in Inflammatory Bowel Disease's surgery: the real clinical cost analysis

P345 Capsule endoscopy in the diagnostic process of suspected Crohn's Disease

P346 Influence of diagnostic delay on ulcerative colitis characteristics at disease onset

P347 Practical recommendations for the collection of the patient-reported outcomes included in the Health Outcomes Observatory (H2O) core data set for patients with inflammatory bowel disease

P348 Disease trajectories in ulcerative colitis: Early identification of patients with endoscopic remission at Week 52

P349 Faecal Calprotectin in Ulcerative Colitis - Associations with Mucosal Inflammatory Activity and Disease Extent

P350 Endoscopic sedation in IBD patients: a propensity score-matched retrospective study

P351 Validation of anterior thigh ultrasound for screening of sarcopenia and elevated body fat in Inflammatory Bowel Disease

P352 Occurrence of moderate to severe anaemia and utilization and efficacy of intravenous iron therapies in a nationwide cohort of Inflammatory Bowel Disease patients

P353 Ulcerative Colitis in the IBSEN III study: Frequent use of biologics and low colectomy rates first year of disease.

P354 Application of the clinical decision support tool to predict treatment outcomes in Crohn’s Disease patients treated with vedolizumab subcutaneous formulation

P355 Motility in small bowel strictures in Crohn’s Disease measured with cine-MRI

P356 CRAB Score, An Indian Insight into in hospital and long-term Colectomy following Acute Severe Ulcerative Colitis (ASUC)

P357 Intestinal ultrasound as a promising non-invasive monitoring tool in patients with Ulcerative Colitis

P358 Long-term clinical outcomes of intestinal Behçet’s disease: a 30-year cohort study at a tertiary hospital in South Korea

P359 Evaluation of usability and performance of home fecal sampling using a dedicated device

P360 Role of intestinal ultrasound scores in the diagnosis of post-operative recurrence in Crohn's disease

P361 Risk of persistent gastrointestinal inflammation after treatment with immune checkpoint inhibitors

P362 Systematic review: Oncological outcomes of patients with Inflammatory Bowel Disease undergoing segmental colonic resections for colorectal cancer and dysplasia

P363 Depression and anxiety in Clostridioides difficile infection compared with inflammatory bowel disease during the Covid-19 pandemic

P364 Presence of malnutrition adversely affects short-term clinical outcomes in a sample of patients with Crohn's disease (CD)

P365 Psoriasis in Inflammatory Bowel Disease: Comparison of Extraintestinal Manifestations and Effect of Anti-TNF Therapies

P366 genomics analysis and differentiation of Crohn's Disease, Intestinal Tuberculosis and Primary Intestinal Iymphoma

P367 Significant impact on health care utilization upon implementation of an electronic IBD care management program.

P368 The presence of extra-intestinal manifestations is associated with poor prognosis in acute severe ulcerative colitis: A KASID multicenter study

P369 Do teenager and adult onset Crohn´s disease patients have different outcomes? A Portuguese cohort study

[1] 2 > >>

ECCO'24 Abstracts

Poster Presentations: Clinical: Diagnosis and Outcome 2023